The ASX200 has been up 0.26% at 8,236 points.
The gains have been less than expected amid investor caution about a potential negative reaction by China’s markets to vague stimulus announcements on the weekend.
Back home, CBA’s head of Australian economics says several surveys indicate the disinflationary process has gathered momentum in the September quarter. However, the Q3 CPI data on October 30 is regarded as the strongest inflation indicator.
Sectors are a mixed bag. Materials are leading strongly, up 2.25%, followed by Health Care, up 0.64% and Financials up 0.34%.
Discretionary is the worst performer, down 1%, followed by IT, down 0.7% and Utilities, 0.4%.
Power and communications infrastructure provider GenusPlus (ASX:GNP) has been up nearly 2% on news its buying Partum Engineering. The binding conditional deal is worth $16 million.
Genus Plus has been $2.64.
Lincoln Minerals (ASX:LML) is set to kick off fieldwork sampling exploration work at its Yallunda uranium play in South Australia.
Lincoln Minerals has been trading at six tenths of a cent.
LTR Pharma (ASX:LTP) has been down half a percent 0.52% on final study results showing its ‘nasal viagra’ drug SPONTAN is absorbed 470% faster than oral tablets.
LTR Pharma has been $1.92.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。